The Asia Pacific embolization coils market is expected to grow from US$ 267.89 million in 2022 to US$ 356.04 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.
Mounting Applications of Embolization Coils
The increasing implementation of embolization coils in the embolotherapy for the treatment of endovascular disease, traumatic injuries, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions is expected to offer an opportunity for the embolization coils market revenue growth in the coming years. Embolization is a minimally invasive procedure to treat an aneurysm by packing it with material that closes the injured place and decreases the risk of bleeding. Embolization is performed within the artery (endovascular) through a steerable catheter inserted into the bloodstream and guided to the brain. Further, post-traumatic bleeding embolization is performed to stop bleeding caused by traumatic injuries. The method uses materials to block the affected vessel and stops blood flow. According to a Traumatic Brain Registry Surveillance Report 2021, a traumatic brain injury (TBI) is a disruption in a normal function of the brain that can be caused by a bump, blow, or jolt to the head or a penetrating head injury. Further, it has also been stated that TBIs are a major cause of death and disability, making these injuries a significant public health problem across the US. In Tennessee, ~24,382 TBI-related ED visits, hospitalizations, and deaths occurred during 2019. Thus, the rising adoption of embolization coils in various applications further increases the demand for embolization coils and supportive devices. Therefore, the growing adoption of embolization coils in embolotherapy is expected to boost the Asia Pacific embolization coils market growth opportunities in the upcoming forecast period.
Asia Pacific Embolization Coils Market Overview
The Asia Pacific embolization coils market segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia Pacific region is expected to be the fastest growing region due to the increasing prevalence of chronic diseases, rising geriatric population, new product development, and international players entering the region. The incidences of the stroke have increased in the past years and the incidences of the abdominal aortic aneurysm has increased in the country. Therefore, the demands for the embolization coils are likely to increase in the coming future. Moreover, in China to meet the healthcare needs of the population the country has developed Healthy China 2030.
Asia Pacific embolization coils Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific embolization coils market Segmentation
The Asia Pacific embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the Asia Pacific embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.
Based on material, the Asia Pacific embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.
Based on application, the Asia Pacific embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.
Based on end user, the Asia Pacific embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.
Based on country, the Asia Pacific embolization coils market is segmented into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The China dominated the market share in 2022.
Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the Asia Pacific embolization coils market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 267.89 Million |
| Market Size by 2028 | US$ 356.04 Million |
| CAGR (2022 - 2028) | 4.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Embolization Coils Market is valued at US$ 267.89 Million in 2022, it is projected to reach US$ 356.04 Million by 2028.
As per our report Asia Pacific Embolization Coils Market, the market size is valued at US$ 267.89 Million in 2022, projecting it to reach US$ 356.04 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Asia Pacific Embolization Coils Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Embolization Coils Market report:
The Asia Pacific Embolization Coils Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Embolization Coils Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Embolization Coils Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Embolization Coils Market
